SCHEMBL7985540

SCHEMBL7985540

O=C(Nc1oc(-c2ccccc2-c2cccc(O)c2)nc1-c1ccc(Cl)cc1)c1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 3/20 0.47
FLT1 P17948 1/20 0.47
FLT4 P35916 1/20 0.47
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
SERPINE1 P05121 3/20 0.45
SUCNR1 Q9BXA5 1/20 0.44
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
KDM4E B2RXH2 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.43
ALOX15 P16050 1/20 0.43
ALOX12 P18054 1/20 0.43
CXCR5 P32302 1/20 0.43
APLNR P35414 1/20 0.43
OPRK1 P41145 1/20 0.43
CCR6 P51684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746601 0.94 KDR (0.53) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744061 0.92 KDR (0.50) KDRFLT1FLT4SERPINE1AKR1C4
SCHEMBL7739071 0.89 KDR (0.43) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7746655 0.89 KDR (0.43) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744809 0.88 AKR1C4 (0.41) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7744087 0.88 KDR (0.46) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7739089 0.88 KDR (0.60) KDRFLT1FLT4KDM4ESMN1; SMN2
SCHEMBL7744170 0.85 F2 (0.45) KDRFLT1FLT4KDM4ESMN1; SMN2
SCHEMBL7985537 0.85 KDR (0.53) KDRFLT1FLT4MEN1KMT2A
SCHEMBL7746570 0.84 KDR (0.49) KDRFLT1FLT4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6228871-B1 THIAZOLE OR OXAZOLE DERIVATIVE TYROSINE KINASE INHIBITORS; ANTICARCINOGENIC AGENTS; AUTOIMMUNE DISEASES; DIABETIC RETINOPATHY MERCK & CO., INC. 2001-05-08 US disclosed